Zhiqiang Li
Jiangxi University of Traditional Chinese Medicine(CN)Nanchang University(CN)First Affiliated Hospital of Jiangxi Medical College(CN)First Affiliated Hospital of Nanchang University(CN)Tsinghua University(CN)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Estrogen and related hormone effects, Gene Regulatory Network Analysis, HER2/EGFR in Cancer Research, Hippo pathway signaling and YAP/TAZ
Most-Cited Works
- → ESR1 ligand-binding domain mutations in hormone-resistant breast cancer(2013)1,235 cited
- → Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway(2018)508 cited
- → PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer(2015)434 cited
- → Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists(2016)364 cited
- → INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors(2021)156 cited
- → Angiomotin-like2 Gene (amotl2) Is Required for Migration and Proliferation of Endothelial Cells during Angiogenesis(2011)77 cited